Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00689260 · ClinicalTrials.gov registry record · Phase 4
Easypod United States User Trial
A Phase 4 study, sponsored by EMD Serono.
- Completed
- Registry status
- Phase 4
- Development phase
- 42
- Enrollment target
NCT00689260 is a Phase 4 study that has completed, run by EMD Serono. The registered enrollment target is 42 participants.
The verdict
NCT00689260, a Phase 4 study, has completed, sponsored by EMD Serono.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study will help to determine whether an injection log on a recombinant human growth hormone (rhGH) delivery device improves subjects' adherence with injection schedules. Adherence will be compared between a group of subjects who are aware of the injection log on the easypod™ rhGH delivery device and a group of subjects who are not aware of the easypod™ injection log. It is the study hypothesis that subject non-adherence rate is different for those who are aware of the injection log capability versus those who are unaware of the injection log capability. Subject perception will also be evaluated by comparing the ease and convenience of use and subject preference for the easypod™ compared to two other rhGH pen injection devices.
Interventions
- DEVICE easypod
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00689260
The ClinicalTrials.gov registry entry for NCT00689260 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EMD Serono, which has 71 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which easypod is the first listed.
NCT00689260 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00689260 about?
NCT00689260 is a clinical study titled "Easypod United States User Trial". This study will help to determine whether an injection log on a recombinant human growth hormone (rhGH) delivery device improves subjects' adherence with injection schedules. Adherence will be compared between a group of subjects who are aware of the injection log on the easypod™ rhGH delivery devic...
What is the current status of trial NCT00689260?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 42 participants. The study started on 2008-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00689260?
The interventions under investigation include: easypod (DEVICE).
Who is sponsoring clinical trial NCT00689260?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.